These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2597224)

  • 1. Suppression of atherogenesis in cholesterol-fed rabbits treated with nilvadipine, a new vasoselective calcium entry blocker.
    Koibuchi Y; Sakai S; Miura S; Ono T; Shibayama F; Ohtsuka M
    Atherosclerosis; 1989 Oct; 79(2-3):147-55. PubMed ID: 2597224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged inhibitory effects of nilvadipine (FR34235) following washout in isolated rabbit aorta and mesenteric artery.
    Furuta T
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):134-8. PubMed ID: 2452305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nilvadipine as a neuroprotective calcium entry blocker in a rat model of global cerebral ischemia. A comparative study with nicardipine hydrochloride.
    Takakura S; Sogabe K; Satoh H; Mori J; Fujiwara T; Totsuka Z; Tokuma Y; Kohsaka M
    Neurosci Lett; 1992 Jul; 141(2):199-202. PubMed ID: 1436634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nilvadipine on regional cerebral blood flow and skin blood flow in anesthetized cats.
    Takakura S; Satoh Y; Satoh H; Mori J; Kohsaka M
    Arch Int Pharmacodyn Ther; 1992; 319():38-48. PubMed ID: 1285672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nilvadipine inhibits acute rise of aqueous flare and intraocular pressure induced by prostaglandin E2 in pigmented rabbits.
    Zhang XY; Hiraki S; Hayasaka S
    Ophthalmic Res; 1998; 30(3):135-41. PubMed ID: 9618717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective action of a calcium antagonist, nilvadipine, against aortic calcium deposition--a pathogenic factor in atherosclerosis.
    Mutoh S; Nomoto A; Sekiguchi C; Yamaguchi I
    Atherosclerosis; 1988 Oct; 73(2-3):181-9. PubMed ID: 3263872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonist. Effect on cuff-induced intimal thickening of rabbit carotid artery.
    Nomoto A; Hirosumi J; Sekiguchi C; Mutoh S; Yamaguchi I; Aoki H
    Atherosclerosis; 1987 Apr; 64(2-3):255-61. PubMed ID: 3606723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ineffectiveness of Ca2+-antagonists nicardipine and diltiazem on experimental atherosclerosis in cholesterol-fed rabbits.
    Naito M; Kuzuya F; Asai K; Shibata K; Yoshimine N
    Angiology; 1984 Oct; 35(10):622-7. PubMed ID: 6497046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits.
    Willis AL; Nagel B; Churchill V; Whyte MA; Smith DL; Mahmud I; Puppione DL
    Arteriosclerosis; 1985; 5(3):250-5. PubMed ID: 3994582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible mechanism for the anti-atherosclerotic action of the calcium channel blocker AE0047 in cholesterol-fed rabbits.
    Hayashi K; Imada T; Yamauchi T; Kido H; Shinyama H; Matzno S; Nakamura N; Kagitani Y
    Clin Exp Pharmacol Physiol; 1998 Jan; 25(1):17-25. PubMed ID: 9493553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist.
    Honerjäger P; Seibel K
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S15-21. PubMed ID: 1283184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of nicardipine on cholesterol-fed S.H.R].
    Ohba T; Tonooka M; Kawashima I; Nakayama S; Yasuhara H; Sakamoto K
    Nihon Yakurigaku Zasshi; 1985 Aug; 86(2):93-103. PubMed ID: 4054735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.
    Henry PD; Bentley KI
    J Clin Invest; 1981 Nov; 68(5):1366-9. PubMed ID: 7298856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nilvadipine, a new calcium entry blocker, on systemic blood pressure, cardiac hypertrophy and venous distensibility in spontaneously hypertensive rats.
    Ohtsuka M; Sakai S; Miura S; Kurosaki M; Koibuchi Y; Ono T; Shibayama F
    Arch Int Pharmacodyn Ther; 1989; 301():228-45. PubMed ID: 2533860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nilvadipine on neuronal function in the ischemic cat brain.
    Takakura S; Furuichi Y; Satoh H; Mori J; Kohsaka M
    Surg Neurol; 1992 Apr; 37(4):255-60. PubMed ID: 1595035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New dihydropyridine drug, nilvadipine, blocks the calcium slow action potential in rat-cultured aortic smooth muscle cells.
    Bkaily G; Molyvdas PA; Ousterhout J; Sperelakis N
    Eur J Pharmacol; 1986 May; 124(1-2):59-65. PubMed ID: 3720845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of two calcium channel blockers--nifedipine and diltiazem--on atherogenesis in hypercholesterolemic hamster.
    Raicu M; Pojoga L; Simionescu N; Simionescu M
    J Submicrosc Cytol Pathol; 1996 Apr; 28(2):265-75. PubMed ID: 8964051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nicardipine on lipid peroxidation in rabbits given 2% cholesterol diet.
    Ismail NM; Jaarin K; Vasudevan SK; Hashim S
    Pharmacol Toxicol; 1995 Jul; 77(1):10-5. PubMed ID: 8532606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.